Core Insights - DuPont de Nemours, Inc. reported a third-quarter 2025 profit from continuing operations of $308 million, or 70 cents per share, down from $453 million, or $1.06 per share, in the same quarter last year. Adjusted earnings were $1.09 per share, exceeding the Zacks Consensus Estimate of $1.04 [1][8] Financial Performance - DuPont's net sales reached $3,072 million, reflecting a 7% year-over-year increase and surpassing the Zacks Consensus Estimate of $2,627 million. Organic sales grew by 6%, driven by a 7% rise in volume, partially offset by a 1% decline in pricing. Foreign currency had a positive impact of 1% [2] - The ElectronicsCo segment recorded net sales of $1,275 million, an 11% increase year-over-year, beating the Zacks Consensus Estimate of $1,216 million. Organic sales grew 10%, supported by an 11% increase in volume, with a 1% decline in pricing. Semiconductor Technologies experienced high-single-digit organic growth due to strong end-market demand, particularly from advanced nodes and AI technology applications [3] - The IndustrialsCo segment reported net sales of $1,797 million, up 5% year-over-year, but missed the Zacks Consensus Estimate of $2,097 million. Organic sales rose 4%, with a 5% increase in volume, offset by a 1% decline in pricing. Healthcare & Water Technologies showed high-single-digit organic growth [4] Financial Position - At the end of the quarter, DuPont had cash and cash equivalents of $1,955 million, a 6.1% increase year-over-year. Long-term debt stood at $7,049 million, up approximately 31.9%. The company generated operating cash flow from continuing operations of $1,260 million for the nine months ended September 30, 2025 [5] Future Outlook - For the fourth quarter of 2025, DuPont expects net sales of approximately $1,685 million, operating EBITDA of around $385 million, and adjusted EPS of about 43 cents. For the full year 2025, net sales are projected to reach roughly $6,840 million, with operating EBITDA estimated at $1,600 million and adjusted EPS expected to be approximately $1.66 [6] Stock Performance - DuPont's shares have declined by 54.2% over the past year, compared to a 40.3% decline in the industry [7]

Core Insights - DuPont de Nemours, Inc. reported a profit from continuing operations of $238 million or 54 cents per share for Q2 2025, an increase from $176 million or 40 cents per share in the same quarter last year [1] - The company's adjusted earnings per share (EPS) for the quarter was $1.12, exceeding the Zacks Consensus Estimate of $1.06 [1][8] - DuPont's net sales reached $3,257 million, reflecting a 3% year-over-year increase and surpassing the Zacks Consensus Estimate of $3,215.2 million [2] Sales Performance - Organic sales grew by 2%, driven by a 4% increase in volume, partially offset by a 2% decline in pricing, with foreign currency contributing positively by 1% [2] - The ElectronicsCo segment achieved net sales of $1,170 million, a 6% year-over-year increase, exceeding the Zacks Consensus Estimate of $1,133.8 million [3] - The IndustrialsCo segment recorded net sales of $2,087 million, up 1% year over year, closely matching the Zacks Consensus Estimate of $2,087.5 million [4] Segment Highlights - ElectronicsCo's organic sales grew by 6%, supported by an 8% increase in volume, while Semiconductor Technologies experienced mid-single-digit organic growth due to strong demand from advanced nodes and AI applications [3] - Healthcare & Water Technologies within the IndustrialsCo segment delivered high-single-digit organic growth, while Diversified Industrials faced a low-single-digit decline in organic sales due to weakness in construction markets [4] Financial Overview - DuPont's cash and cash equivalents stood at $1,837 million at the end of the quarter, a 24.5% increase year over year, while long-term debt decreased by 25.7% to $5,326 million [5] - The company generated operating cash flow from continuing operations of $763 million for the first half of 2025 [5] Future Outlook - For Q3 2025, DuPont anticipates net sales of approximately $3,320 million, operating EBITDA of around $875 million, and adjusted EPS of about $1.15 [6] - Full-year 2025 projections include net sales of roughly $12,850 million, operating EBITDA estimated at $3,360 million, and adjusted EPS expected to be approximately $4.40 [6] Stock Performance - DuPont's shares have declined by 8.9% over the past year, compared to a 24.3% decline in the industry [7]